Key Takeaways
- US industrial production remained flat (0.0%) in August, significantly missing economist expectations of a 0.3% increase and signaling a cooling in the manufacturing sector.
- President Trump is set to unveil a nationwide Medicaid drug pricing model covering all 50 states and territories, aiming to link domestic prices to the "most-favored-nation" (MFN) rates paid by other developed countries.
- Fed Vice Chair Michelle Bowman announced an upcoming overhaul of bank stress tests, promising more transparency and predictable capital requirements for major lenders in the "coming weeks."
- US exporters shipped 111,000 tons of soybeans to China, as trade talks between Treasury Secretary Scott Bessent and Chinese officials continue ahead of a high-stakes presidential summit.
- A 6.5 magnitude earthquake struck near Nikolski, Alaska, though authorities reported no tsunami threat and minimal risk of structural damage due to the remote location.
Industrial Output Falters Amid Manufacturing Slump
The U.S. industrial sector showed signs of fatigue in August, with total industrial production recording 0.0% growth, according to Federal Reserve data released Friday. This performance fell short of the 0.3% expansion projected by analysts and followed a revised 0.2% gain in July.
The primary drag on the index was manufacturing output, which dropped 0.3% during the month. Within the sector, motor vehicles and parts saw a 1.2% decline, while mining edged up a marginal 0.1%. Conversely, utilities output surged 1.8%, providing the only significant upward pressure on the headline figure. Capacity utilization remained steady at 76.3%, slightly below the 76.4% forecast.
Trump Administration Scales Up Drug Pricing Reform
The White House is moving forward with a major expansion of its healthcare agenda, with President Trump expected to host governors today to tout a new Medicaid drug pricing model. The plan will reportedly extend "most-favored-nation" pricing to all 50 states, D.C., and Puerto Rico, ensuring Medicaid programs pay no more than the lowest price available in other high-income nations.
The administration has already secured voluntary agreements with 26 pharmaceutical companies, including industry giants like Eli Lilly (LLY), Pfizer (PFE), and Johnson & Johnson (JNJ). These deals currently cover approximately 89% of the branded drug market. Officials estimate the initiative could eventually save Americans over $600 billion by rebalancing international pricing structures.
Fed Signals Regulatory Relief for Big Banks
In a speech delivered in London, Federal Reserve Vice Chair for Supervision Michelle Bowman detailed plans to modernize the U.S. bank regulatory framework. Bowman stated that the Fed will soon finalize a revamped stress test process designed to be more transparent and less volatile for the nation's largest financial institutions.
Key changes include a new rule to average the results of a bank’s two most recent stress tests when setting capital buffers, a move intended to reduce year-to-year fluctuations. Bowman noted that the updated framework will "close the book on an opaque and unnecessarily unpredictable" system, allowing the public and banks to better understand the underlying models and variables used by regulators.
Agricultural Trade and Seismic Activity
On the trade front, US exporters confirmed the shipment of 111,000 tons of soybeans to China. This comes as Treasury Secretary Scott Bessent prepares to meet with Chinese Vice Premier He Lifeng this weekend to discuss agricultural tariff cuts. The talks serve as a precursor to a planned summit between President Trump and President Xi Jinping scheduled for September 24 in Washington.
Separately, the USGS reported a 6.5 magnitude earthquake 169 km west of Nikolski, Alaska, at a depth of approximately 108 km. While the quake was powerful, its depth and remote location in the Aleutian Islands resulted in no tsunami warnings or reported injuries. Experts noted a 43% chance of magnitude 5.0+ aftershocks occurring within the next week.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.